SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol (2021)

First Author: McCarthy C
Attributed to:  MICA: The Newcastle Proximity Laboratory funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 34225765

Publication URI:

Type: Journal Article/Review

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215